Xiaorui Yin

MRgFUS-enabled nanogel platform for synergstic chemo-immunotherapy in glioblastoma

Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with poor prognosis and limited responsiveness to temozolomide (TMZ)-based chemoradiotherapy. Treatment remains hindered by the blood-brain barrier (BBB), blood-brain tumor barrier (BBTB), acquired TMZ resistance, a...